Laboratory for Molecular Diagnostics
Center for Nephrology and Metabolic Disorders
Moldiag Diseases Genes Support Contact

V-akt murine thymoma viral oncogene homolog 2

The AKT2 gene ancodes a serine/threonine kinase that seems to be involved in signal transduction. It is also a putative oncogene. Two mutations are described so far a gain-of-function mutation causes hypoinsulinemic hypoglycemia and a loss-of-function mutation leads to diabetes type 2. Inheritance is autosomal dominant in both mutations.


Clinic Method Carrier testing
Turnaround 5 days
Specimen type genomic DNA
Clinic Method Massive parallel sequencing
Turnaround 25 days
Specimen type genomic DNA
Clinic Method Genomic sequencing of the entire coding region
Turnaround 25 days
Specimen type genomic DNA

Related Diseases:

Hypoinsulinemic hypoglycemia



Hussain K et al. (2011) An activating mutation of AKT2 and human hypoglycemia.

external link

Cho H et al. (2001) Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta).

external link

Peng XD et al. (2003) Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2.

external link

Garofalo RS et al. (2003) Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta.

external link

Cheng JQ et al. (1992) AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas.

external link

Woulfe D et al. (2004) Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2.

external link

George S et al. (2004) A family with severe insulin resistance and diabetes due to a mutation in AKT2.

external link

Li X et al. (2007) Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1alpha transcription coactivator.

external link

Semple RK et al. (2009) Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis.

external link

None (1987) Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma.

external link

Cheng JQ et al. (1996) Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA.

external link

Altomare DA et al. (1996) Chromosome mapping of the mouse Akt2 gene and Akt2 pseudogene.

external link

Orphanet article

Orphanet ID 201112 external link

NCBI article

NCBI 208 external link

OMIM.ORG article

Omim 164731 external link

Wikipedia article

Wikipedia EN (AKT2) external link
Update: Aug. 14, 2020
Copyright © 2005-2022 by Center for Nephrology and Metabolic Disorders, Dr. Mato Nagel, MD
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Germany, Tel.: +49-3576-287922, Fax: +49-3576-287944
Sitemap | Webmail | Disclaimer | Privacy Issues | Website Credits